3 min read

5 Reasons Why You Need a Pharmacovigilance Partner

The mix of products and size of company can determine how critical this partner is.
Dive into the list curated by UBC's safety and risk management experts.

Outsourcing partner experts offer services in a wide range of areas, for instance, medical, regulatory, and technology, that are necessary for top quality safety surveillance and pharmacovigilance. Outsourcing provides rapid access to expert professionals, eliminating the need to hire, train, and retain staff.

Eliminate Burden of Implementing SOPs
Developing the right systems and SOPs to support long-term pharmacovigilance activities is very time-consuming and costly. Start-up or virtual pharma and biotech companies, in particular, look to external partners who have systems and procedures already in place, eliminating the time, risk, and expense of implementing company solutions. Outsourcing partner SOPs can be implemented quickly and are proven to pass regulatory inspections.

The right partner can conform to the needs of each unique company, and as the products progress through the development lifecycle, can follow the company’s development plans to build a pragmatic and compliant system to meet requirements without incurring unnecessary expense.

Leverage Existing Resources
Service providers can “plug and play” into your systems or plug you into theirs. External partners can rapidly provide staff who have system, therapeutic, and regional expertise.  Leveraging this expertise allows programs to be initiated quickly and to your specifications with the pharmacovigilance partner acting as an extension of the company. This allows the internal team to focus on their core competencies

An external partner can be used to complete all of your needs or a subset of activities, such as safety writing, literature review, local pharmacovigilance, and QPPV services in the EU, processing excess case volume.

In any model, the outsourcing of pharmacovigilance activities must be carefully planned to achieve success. With the right partner, collaboration takes place at every step in order to build strong processes and set clear expectations. This type of scalable, flexible, and efficient partnership will lead to a winning situation for all: the sponsor, the external partner, and the patients.

Are you PV ready? Evaluate your program using our complimentary safety readiness checklist here

Other Recent Posts

3 min read

UBC Appoints Anthony Luttenberger Chief Commercial Officer

Biopharma services industry veteran brings decades of experience spanning late-stage, clinical trials, & post-approval commercial support.
1 min read

UBC Listed as a Citeline Awards Finalist for Excellence in RWE

UBC is once again a finalist for the Citeline Awards, with our 2024 nomination coming in the Excellence in RWE category.
3 min read

UBC Recognized as a Citeline Awards Finalist Again

The Citeline Awards have recognized UBC & Seqster’s innovative collaboration as a shortlisted finalist for the Best Patient-Facing Technology Initiative Category in 2023.

Thank You for Connecting with UBC

Lorem ipsum dolor sit amet consectetur. Mi proin enim ipsum nascetur. Venenatis odio scelerisque non netus ac et pellentesque.

What You Can Expect Next

Lorem ipsum dolor sit amet consectetur. Cras aliquam erat eget magna sollicitudin.

Get Ready to Change Your Business

Lorem ipsum dolor sit amet consectetur. Mi proin enim ipsum nascetur. Venenatis odio scelerisque non netus ac et pellentesque.

Service Request

Bekki Bracken Brown

President & Chief Executive Officer

Bekki Bracken Brown serves as the President and CEO of UBC, guiding the company’s mission and values, including the improvement of access for patients to receive better outcomes. She oversees all aspects of UBC, such as operations, business growth strategy, sales and marketing, and acquisition support.

With over 20 years of industry experience, Ms. Brown brings knowledge from a successful career in senior management from her tenure at Quintiles, INC Research, and, most recently, with Syneos Health. She’s been a member of the North Carolina BIO Board of Directors since 2019. She is also a member of the Healthcare Businesswomen’s Association — Southeast Chapter and CHIEF, an organization that supports women executive leaders. Ms. Brown earned her bachelor’s degree at Duke University.